[1]
|
郑杭生, 程碧欣, 朴寄纲, 等. 基于生物药剂学与药物动力学知识链的课程思政元素挖掘[J]. 药学教育, 2023, 39(1): 26-30. https://doi.org/10.16243/j.cnki.32-1352/g4.2023.01.004
|
[2]
|
田锁燕, 贾国香, 胡静雯, 等. 基于生理学的药动学/生物药剂学模型在中药药动学研究中的应用进展[J]. 中草药, 2023, 54(20): 6903-6912. https://doi.org/10.7501/j.issn.0253-2670.2023.20.033
|
[3]
|
国家药典委员会. 中国药典[M]. 北京: 中国医药科技出版社, 2020.
https://db2.ouryao.com/yd2020/view.php?id=f3bd4333ab, 2023-12-01.
|
[4]
|
张远冬, 高健美, 龚其海. 超高效液相色谱-串联质谱法测定不同pH值溶液中三叶苷平衡溶解度和表观油水分配系数[J]. 医药导报, 2021, 40(9): 1242-1246. https://doi.org/10.3870/j.issn.1004-0781.2021.09.015
|
[5]
|
曹麒麟, 韩晓璐, 高静, 等. 提高难溶性药物生物利用度的研究进展[J]. 湖北科技学院学报(医学版), 2021, 35(4): 352-356. https://doi.org/10.16751/j.cnki.2095-4646.2021.04.0352
|
[6]
|
Wen, C.J., Chiang, C.F., Lee, C.S., et al. (2022) Double Nutri (Liposomal Encapsulation) Enhances Bioavailability of Vitamin C and Extends Its Half-Life in Plasma. Journal of Biomedical Nanotechnology, 18, 922-927.
https://doi.org/10.1166/jbn.2022.3274
|
[7]
|
Xing, Y., Li, X., Cui, W., et al. (2022) Glucose-Modified Zein Nanoparticles Enhance Oral Delivery of Docetaxel. Pharmaceutics, 14, Article No. 1361. https://doi.org/10.3390/pharmaceutics14071361
|
[8]
|
Kamran, M., Khan, M.A., Shafique, M., et al. (2022) In-Vivo Formulation Design, Characterization and Assessment of Cefixime Loaded Binary Solid Lipid Nanoparticles to Enhance Oral Bioavailability. Journal of Biomedical Nanotechnology, 18, 1215-1226. https://doi.org/10.1166/jbn.2022.3313
|
[9]
|
Ke, Z., Shi, J., Cheng, Z., et al. (2022) Design and Characterization of Gambogic Acid-Loaded Mixed Micelles System for Enhanced Oral Bioavailability. Pharmaceutical Development and Technology, 27, 695-701.
https://doi.org/10.1080/10837450.2022.2107012
|
[10]
|
Dana, P., Pimpha, N., Chaipuang, A., et al. (2022) Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy. Nanomaterials (Basel), 12, Article No. 2606.
https://doi.org/10.3390/nano12152606
|
[11]
|
Ebrahimian, M., Hashemi, M., Etemad, L., et al. (2022) Thymoquinone-Loaded Mesenchymal Stem Cell-Derived Exosome as an Efficient Nano-System against Breast Cancer Cells. Iranian Journal of Basic Medical Sciences, 25, 723-731.
|
[12]
|
Gibiansky, L., Passey, C., Voellinger, J., et al. (2022) Population Pharmacokinetic Analysis for Tisotumab Vedotin in Patients with Locally Advanced and/or Metastatic Solid Tumors. CPT: Pharmacometrics & Systems Pharmacology, 11, 1358-1370. https://doi.org/10.1002/psp4.12850
|
[13]
|
Fu, C., Pei, Q., Liang, W., et al. (2022) Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease. Drug Design, Development and Therapy, 16, 2261-2274. https://doi.org/10.2147/DDDT.S362607
|
[14]
|
马中兴. 浅谈药物半衰期与合理用药[J]. 中国医药指南, 2015, 13(33): 286-287.
https://doi.org/10.15912/j.cnki.gocm.2015.33.229
|
[15]
|
Kim, H., Maeng, H., Kim, J.H., et al. (2022) Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease. International Journal of Molecular Sciences, 23, Article No. 8618.
https://doi.org/10.3390/ijms23158618
|
[16]
|
薛源, 赵宇蕾, 齐谢敏, 等. 有限采样法估算肾病患儿口服咪唑立宾药时曲线下面积模型的建立与验证[J]. 医学研究生学报, 2020, 33(9): 968-973. https://doi.org/10.16571/j.cnki.1008-8199.2020.09.014
|
[17]
|
Zhou, B., Xiong, W., Bai, K., et al. (2022) Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit. Frontiers in Pediatrics, 10, Article ID: 867712.
https://doi.org/10.3389/fped.2022.867712
|
[18]
|
Zhao, J., Fan, Y., Yang, M., et al. (2022) Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study. Antibiotics, 11, Article No. 837. https://doi.org/10.3390/antibiotics11070837
|
[19]
|
李瑞, 张青, 辛洪亮. 生物药剂学与药物动力学实验教学改革探讨[J]. 教育教学论坛, 2019, 19(5): 261-262.
|
[20]
|
姜福林, 管宴萍, 陈江英, 等. 基于规范性、溯源性和科学性的药代动力学实验教学改革[J]. 药学教育, 2019, 35(4): 76-79. https://doi.org/10.16243/j.cnki.32-1352/g4.2019.04.020
|
[21]
|
梁健钦, 李世杰, 黎芳, 等. 《生物药剂学与药物动力学》实验教学改革的几点思路[J]. 大众科技, 2018, 20(11): 76-78. https://doi.org/10.19378/j.issn.1003-9783.2023.03.014
|
[22]
|
何晓明, 杨少坤, 党云洁, 等. 药物动力学双室模型静脉注射给药模拟实验设计[J]. 天津药学, 2020, 32(3): 1-4.
https://doi.org/10.3969/j.issn.1006-5687.2020.03.001
|
[23]
|
赵凯悦, 张哲铭, 何朝星, 等. 药物动力学单室模型血管外给药的教学实验设计[J]. 中国现代教育装备, 2021(19): 58-60. https://doi.org/10.13492/j.cnki.cmee.2021.19.018
|
[24]
|
张哲铭, 赵凯悦, 何朝星, 等. 药物动力学单室模型静滴给药的模拟实验设计及应用[J]. 现代职业教育, 2021(20): 86-87.
|
[25]
|
Liu, X.L., Guan, Y.P., Wang, Y., et al. (2022) Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients. Frontiers in Pharmacology, 13, Article ID: 891648.
https://doi.org/10.3389/fphar.2022.891648
|
[26]
|
Chen, C.Y., Xiu, D., Ran, W., et al. (2022) Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients with Multiple Sclerosis: Analyses of Published Clinical Trials. Frontiers in Pharmacology, 13, Article ID: 824232. https://doi.org/10.3389/fphar.2022.824232
|
[27]
|
Li, A., Mak, W.Y., Ruan, T., et al. (2023) Population Pharmacokinetics of Amisulpride in Chinese Patients with Schizophrenia with External Validation: The Impact of Renal Function. Frontiers in Pharmacology, 14, Article ID: 1215065. https://doi.org/10.3389/fphar.2023.1215065
|
[28]
|
Thoueille, P., Delarive, L., Cavassini, M., et al. (2023) Population Pharmacokinetic Analysis of Doravirine in Real-World People with HIV. British Journal of Clinical Pharmacology.
https://doi.org/10.22541/au.169782683.33841109/v1
|
[29]
|
Hu, L., Huang, S., Huang, Q., et al. (2023) Population Pharmacokinetics of Voriconazole and the Role of CYP2C19 Genotype on Treatment Optimization in Pediatric Patients. PLOS ONE, 18, e0288794.
https://doi.org/10.1371/journal.pone.0288794
|
[30]
|
Hoa, P.Q., Kuk, K.H., Jang, T.W., et al. (2023) Population Pharmacokinetic Model of Rifampicin for Personalized Tuberculosis Pharmacotherapy: Effects of SLCO1B1 Polymorphisms on Drug Exposure. International Journal of Antimicrobial Agents, 63, Article ID: 107034. https://doi.org/10.1016/j.ijantimicag.2023.107034
|
[31]
|
Li., Z., Yang, S., Hua, Z., et al. (2023) Population Pharmacokinetics of Rivaroxaban in Chinese Deep Vein Thrombosis Patients and the Exposure Simulation for Dosing Recommendation. Naunyn-Schmiedeberg’s Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02798-7
|
[32]
|
Dvořáčková, E., Šíma, M., Zajacová, A., et al. (2023) Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model. Antibiotics, 12, Article No. 1399.
https://doi.org/10.3390/antibiotics12091399
|
[33]
|
Van Der Laan, L.E., Garcia-Prats, A.J., McIlleron, H., et al. (2023) Optimizing Dosing of the Cycloserine Prodrug Terizidone in Children with Rifampicin-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy, 67, e0061123.
https://doi.org/10.1128/aac.00611-23
|
[34]
|
Lass, J., Leroux, S., Kõrgvee, L.T., et al. (2023) Pharmacokinetics of Oral Spironolactone in Infants up to 2 Years of Age. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-023-03599-w
|
[35]
|
Mimram, L., Magréault, S., Kerroumi, Y., et al. (2023) What Clindamycin Dose Should Be Administered by Continuous Infusion during Combination Therapy with Rifampicin? A Prospective Population Pharmacokinetics Study. The Journal of Antimicrobial Chemotherapy, 78, 2943-2949. https://doi.org/10.1093/jac/dkad335
|
[36]
|
Bock, M., Van Hasselt, J.G.C., Schwartz, F., et al. (2023) Rifampicin Reduces Plasma Concentration of Linezolid in Patients with Infective Endocarditis. The Journal of Antimicrobial Chemotherapy, 78, 2840-2848.
https://doi.org/10.1093/jac/dkad316
|
[37]
|
Moein, A., Lu, T., Jönsson, S., et al. (2022) Population Pharmacokinetic Analysis of Etrolizumab in Patients with Moderately-to-Severely Active Ulcerative Colitis. CPT: Pharmacometrics & Systems Pharmacology, 11, 1244-1255.
https://doi.org/10.1002/psp4.12846
|
[38]
|
Van De Velde, M.E., Uittenboogaard, A., Yang, W., et al. (2022) Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients. Cancers, 14, Article No. 3510. https://doi.org/10.3390/cancers14143510
|
[39]
|
Gao, Y., Davies Forsman, L., Ren, W., et al. (2021) Drug Exposure of First-Line Anti-Tuberculosis Drugs in China: A Prospective Pharmacological Cohort Study. British Journal of Clinical Pharmacology, 87, 1347-1358.
https://doi.org/10.1111/bcp.14522
|
[40]
|
Cho, Y.S., Jang, T.W., Kim, H.J., et al. (2021) Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients with Tuberculosis Based on Target Attainment Analysis. The Journal of Clinical Pharmacology, 61, 1567-1578. https://doi.org/10.1002/jcph.1931
|
[41]
|
Panjasawatwong, N., Wattanakul, T., Hoglund, R.M., et al. (2020) Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis. Antimicrobial Agents and Chemotherapy, 65, e00487-e520. https://doi.org/10.1128/AAC.00487-20
|
[42]
|
Cojutti, P.G., Tedeschi, S., Gatti, M., et al. (2022) Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring. Antibiotics, 11, Article No. 996. https://doi.org/10.3390/antibiotics11080996
|
[43]
|
Courlet, P., Cardoso, E., Bandiera, C., et al. (2022) Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics, 14, Article No. 1317.
https://doi.org/10.3390/pharmaceutics14071317
|
[44]
|
Wojciechowski, J.S., Purohit, V., Huh, Y., et al. (2023) Evolution of Ritlecitinib Population Pharmacokinetic Models during Clinical Drug Development. Clinical Pharmacokinetics, 62, 1765-1779.
https://doi.org/10.1007/s40262-023-01318-3
|
[45]
|
Hüppe, T., Götz, K.M., Meiser, A., et al. (2023) Population Pharmacokinetic Modeling of Multiple-Dose Intravenous Fosfomycin in Critically Ill Patients during Continuous Venovenous Hemodialysis. Scientific Reports, 1, Article No. 18132. https://doi.org/10.1038/s41598-023-45084-5
|
[46]
|
Barreto, E.F., Chang, J., Rule, A.D., et al. (2023) Population Pharmacokinetic Model of Cefepime for Critically Ill Adults: A Comparative Assessment of eGFR Equations. Antimicrobial Agents and Chemotherapy, 67, e0081023.
https://doi.org/10.1128/aac.00810-23
|
[47]
|
李兰城. 蒙药药物代谢动力学研究方法的评价[J]. 北方药学, 2013, 10(1): 77-78.
https://doi.org/10.3969/j.issn.1672-8351.2013.01.075
|
[48]
|
谭银丰, 孙墨箫, 张蕾, 等. LC-MS/MS法测定大鼠血浆中芦荟苦素浓度及其药动学研究[J]. 中国药房, 2021, 32(22): 2701-2705. https://doi.org/10.6039/j.issn.1001-0408.2021.22.03
|
[49]
|
陈君, 黄春新, 王敏. 超高效液相色谱法测定人血清中伏立康唑血药浓度与临床应用[J]. 海南医学, 2021, 32(2): 173-176. https://doi.org/10.3969/j.issn.1003-6350.2021.02.010
|
[50]
|
王石健, 夏修远. 高效液相色谱法测定人血清中替考拉宁的血药浓度及其应用[J]. 海峡药学, 2021, 33(5): 95-97.
https://doi.org/10.3969/j.issn.1006-3765.2021.05.032
|
[51]
|
范晓, 陈怡莹, 姜婕, 等. 药理效应法测定青风藤碱透皮贴剂的药动学参数[J]. 中药新药与临床药理, 2023, 34(3): 391-395. https://doi.org/10.19378/j.issn.1003-9783.2023.03.014
|
[52]
|
崔明宇, 张凯, 邢绪东, 等. 药理效应法测定蓬子菜总黄酮在大鼠体内的药动学参数[J]. 中医药学报, 2018, 46(2): 17-20. https://doi.org/10.19664/j.cnki.1002-2392.180039
|
[53]
|
黄芳, 郭立玮, 金万勤. 药物累积法测定普通马钱子粉与超细马钱子粉的表观药动学参数[J]. 南京中医药大学学报(自然科学版), 2001(3): 162-163. https://doi.org/10.14148/j.issn.1672-0482.2001.03.012
|
[54]
|
杨季菱, 徐宏平, 丁既鹏. 人血浆中头孢克洛高效液相色谱法与微生物法测定[J]. 郑州大学学报(医学版), 2005(5): 911-913. https://doi.org/10.13705/j.issn.1671-6825.2005.05.046
|
[55]
|
张莉蓉, 程能能, 陈斌艳, 等. 高效液相色谱法与微生物法测定人血浆中氧氟沙星浓度的比较[J]. 中国新药与临床杂志, 2003(4): 201-204. https://doi.org/10.3969/j.issn.1007-7669.2003.04.003
|